查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
DNA 合成市场规模、份额和趋势分析报告：按服务类型（基因合成、寡核甘酸合成）、应用（研发、治疗）、最终用途、地区、细分市场预测，2023-2030 年
市场调查报告书
商品编码
1178539

DNA 合成市场规模、份额和趋势分析报告：按服务类型（基因合成、寡核甘酸合成）、应用（研发、治疗）、最终用途、地区、细分市场预测，2023-2030 年

DNA Synthesis Market Size, Share & Trends Analysis Report By Service Type (Gene Synthesis, Oligonucleotide Synthesis), By Application (Research And Development, Therapeutics), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

DNA 合成市场的增长和趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球 DNA 合成市场预计将达到 127.6 亿美元。 该市场预计从 2023 年到 2030 年的复合年增长率为 19.63%，这是由于人们越来越关注个性化基因组测序以协助患者护理决策。 DNA 合成还有可能通过疾病监测、药物发现和药物基因组学等广泛应用彻底改变生物学研究活动。

COVID-19 大流行对采用基于 mRNA 的疫苗治疗 COVID-19 感染和各种类型的癌症产生了积极影响。 mRNA 的可用性推动了对合成 DNA 的需求。 此外，COVID-19 研究的一个主要重点是 DNA 合成。 合成 DNA 用于所有 PCR 分析。 患者应使用 DNA 引物来鑑定样本中潜在的基因组 DNA。

由于□工程的进步，正在开发各种□促 DNA 合成方法。 它使用□将核酸连接成所需序列，需要进一步优化以实现更广泛的应用。 许多市场参与者正在尝试设计新技术，以在最短的周转时间内高效地□促生产核甘酸。 例如，Ribbon Biolabs 的任务是在 2021 年 5 月合成 10,000 个碱基对的 DNA 序列，并在 2021 年 12 月实现了 20,000 个碱基对 DNA 分子的里程碑。

基因合成具有广泛的应用，包括具有特定碱基序列的靶向诱变和所需表型表达的控制。 基因合成是基因工程的基础，开发具有高特异性的抗体片段极大地提高了抗体的种类和质量。

寡核甘酸合成是在实验室中生产具有所需定义序列的相对较短的核酸片段。 该技术是一种极其强大的方法，有助于快速、廉价地获取所需序列的定制寡核甘酸。 公司正在设计他们的寡核甘酸文库以协助核甘酸合成过程。 例如，2022 年 7 月，Ribbon Biolabs 宣布其已获得一项美国专利，涉及一种使用 Ribbon Biolabs 多样化的寡核甘酸库合成核甘酸分子的方法。 在这种方法中，预先构建了一个寡核甘酸库以实现高效访问。

DNA 合成市场报告亮点

按服务类型划分，寡核甘酸合成在 2022 年所占份额最大，原因是合成核甘酸链在研究中的实用性使其需求不断增长

按应用划分，由于生物技术和基于 mRNA 的疫苗等广泛应用对合成核甘酸的需求，研发部门在 2022 年主导了市场。

在最终用途方面，由于利用生物分子疗法的合成核甘酸的应用越来越多，预计生物製药公司部门在预测期内将快速增长。 对新药开发需求的增长也对该领域的增长产生了积极影响。

由于生命科学研究的进步和对新型生物治疗药物的需求激增，北美在 2022 年主导了全球市场。

由于对生物研究和新药发现的需求增加，预计亚太地区将出现显着增长。 此外，主要市场参与者正寻求凭藉其最新的核甘酸生产专业知识进入亚太市场。

内容

第1章调查方法及范围

  • 调查范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 目的

第 2 章执行摘要

  • DNA 合成市场：市场展望

第 3 章市场变量、趋势和范围

  • 市场趋势和前景
  • 趋势分析
    • 服务类型趋势
    • 应用趋势
    • 最终用途趋势
  • 市场细分和范围
  • 市场动态
    • 市场驱动因素分析
      • 合成生物学领域的快速技术进步
      • 增加对研发 (R&D) 活动的投资
    • 市场製约因素分析
      • 潜在的生物安全、生物安保和伦理问题
      • 严格的政府法规和准则
    • 机会分析
  • 2022 年产品渗透率和增长前景图
  • 商业环境分析
    • DNA 合成市场：SWOT 分析，按因素（政治和法律、经济和技术）
    • 波特的五力分析
  • 市场份额分析
    • 公司规模
    • 产品组合
    • 战略举措
  • 竞争格局
    • 战略框架
    • 市场参与分类
      • 新/新进入者
      • 成熟的参与者和领导者

第4章服务业务分析

  • 寡核甘酸合成
    • 标准寡核甘酸合成
    • 定制寡核甘酸合成
  • 基因合成
    • 定制基因合成
    • 基因文库合成

第5章应用分析

  • 研究与开发
  • 诊断
  • 治疗学

第 6 章教育用途分析

  • 生物製药公司
  • 学术和研究机构
  • 委託研究机构

第7章区域业务分析

    • DNA 合成市场：区域差异分析，2022 年和 2030 年
    • 北美
      • 美国
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 加拿大
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
    • 欧洲
      • 德国
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 英国
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 法国
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 意大利
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 西班牙
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 丹麦
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 瑞典
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 挪威
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
    • 亚太地区
      • 日本
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 中国
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 印度
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 澳大利亚
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 泰国
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 韩国
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 拉丁美洲 (LATAM)
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 巴西
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 墨西哥
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 阿根廷
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
    • 中东和非洲 (MEA)
      • 南非
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 沙特阿拉伯
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 阿拉伯联合酋长国
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景
      • 科威特
        • 主要国家动态
        • 监管框架
        • 竞争场景
        • 最近的发展
        • 投资场景

第8章公司简介

  • 公司简介
    • Thermo Fisher Scientific, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 扭曲生物科学
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Bioneer 公司
      • 公司概况
      • 财务业绩
      • 产品基准
      • 战略举措
    • 伊顿生物科学
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • LGC 生物搜索技术
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • IBA 有限公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 欧陆科学
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Integrated DNA Technologies, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 昆塔拉生物科学公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 金斯瑞生物科技股份有限公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
Product Code: GVR-4-68040-009-7

DNA Synthesis Market Growth & Trends:

The global DNA synthesis market size is expected to reach USD 12.76 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 19.63% from 2023 to 2030 owing to the rising focus on personalized genome sequencing that aids determine patient care. In addition, DNA synthesis has the capability to revolutionize biological research activities for widespread applications in disease monitoring, drug discovery, and pharmacogenomics.

The COVID-19 pandemic positively impacted the adoption of mRNA-based vaccines for the treatment of COVID-19 infection and different types of cancers. The utility of mRNA boosts the demand for synthetic DNA. Furthermore, a major focus of COVID-19 research is DNA synthesis. Synthetic DNA is used in all PCR analyses. Patients need to use a DNA primer to identify any genomic DNA that may be present in the sample.

Progress in enzyme engineering is boosting the development of different approaches for enzymatic DNA synthesis. It involves the use of enzymes to chain the nucleic acids together in the required sequence and requires further optimization for its widespread applications. Many market players are striving to devise novel technologies for efficient enzymatic production of nucleotides in the lowest turnaround time. For instance, in May 2021, Ribbon Biolabs set a mission of synthesizing DNA sequences of 10,000 base pairs and accomplished a milestone of a 20,000 base pair DNA molecule by December 2021.

Gene synthesis has a broad spectrum of applications in targeted mutagenesis with a specific sequence of nucleotides along with the regulation of a desired phenotypic expression. It forms the primary basis of genetic engineering, which has significantly leveraged the scope and quality of antibodies by the development of antibody fragments with high specificity.

Oligonucleotide synthesis is the laboratory-based production of relatively short fragments of nucleic acids in a required definitive sequence. The technique is an extremely robust practice that facilitates rapid and inexpensive access to the custom-made oligonucleotides of the desired sequence. Companies have devised their oligonucleotide libraries to aid their nucleotide synthesis processes. For instance, in July 2022, Ribbon Biolabs declared that it secured a U.S. Patent that comprises Ribbon Biolabs' method for the synthesis of a nucleotide molecule using a diverse library of oligonucleotides. The approach comprises a pre-built library of oligonucleotides for efficient access.

DNA Synthesis Market Report Highlights:

  • By service type, oligonucleotide synthesis held the largest share in 2022 due to the rising demand for synthetic nucleotide strands for their utility in research studies
  • By application, the research and development segment dominated the market in 2022 due to the demand for synthetic nucleotides for a wide spectrum of applications in bioengineering and mRNA-based vaccines
  • By end-use, the biopharmaceutical companies segment is expected to grow rapidly over the forecast period owing to a rise in the applications of synthetic nucleotides to leverage bio-molecular therapies. The rise in the demand for novel drug discovery also positively impacts the growth of this segment
  • North America dominated the global market in 2022 owing to emerging advancements in life sciences research and rapidly growing demand for novel bio-therapeutics in the region
  • Asia Pacific is expected to grow considerably due to a rise in the demand for biological research and novel drug discovery. Moreover, key market players are working towards entering the Asia Pacific market with their modern nucleotide production expertise

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Scope
    • 1.1.1 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Objectives
    • 1.6.1 Objective 1
    • 1.6.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 DNA synthesis Market: Market Outlook

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Trends & Outlook
  • 3.2 Trend Analysis
    • 3.2.1 Service Type Trends
    • 3.2.2 Application Trends
    • 3.2.3 End-Use Trends
  • 3.3 Market Segmentation & Scope
  • 3.4 Market Dynamics
    • 3.4.1 Market driver analysis
      • 3.4.1.1 Rapid Technological Advancements in the Field of Synthetic Biology
      • 3.4.1.2 Rising Investments Toward Research & Development (R&D) Activities
    • 3.4.2 Market restraint analysis
      • 3.4.2.1 Potential Biosafety, Biosecurity, and Ethical Issues
      • 3.4.2.2 Stringent Government Regulations & Guidelines
    • 3.4.3 Opportunity analysis
  • 3.5 Penetration & Growth Prospect Mapping for Products, 2022
  • 3.6 Business Environment Analysis
    • 3.6.1 DNA synthesis Market -SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
    • 3.6.2 Porter's Five Forces Analysis
  • 3.7 Market Share Analysis
    • 3.7.1 Company Size
    • 3.7.2 Product portfolio
    • 3.7.3 Strategic Initiatives
  • 3.8 Competitive Landscape
    • 3.8.1 Strategy Framework
    • 3.8.2 Market Participation Categorization
      • 3.8.2.1 New/ emerging entrants
      • 3.8.2.2 Mature players & leaders

Chapter 4 Services Type Business Analysis

  • 4.1 Oligonucleotide Synthesis
    • 4.1.1 Global DNA synthesis market for oligonucleotide synthesis, 2018 - 2030 (USD Million)
    • 4.1.2 Standard Oligonucleotide Synthesis
      • 4.1.2.1 Global DNA synthesis market for standard oligonucleotide synthesis, 2018 - 2030 (USD Million)
    • 4.1.3 Custom Oligonucleotide Synthesis
      • 4.1.3.1 Global DNA synthesis market for custom oligonucleotide synthesis, 2018 - 2030 (USD Million)
  • 4.2 Gene Synthesis
    • 4.2.1 Global DNA synthesis market for gene synthesis, 2018 - 2030 (USD Million)
    • 4.2.2 Custom Gene Synthesis
      • 4.1.2.1 Global DNA synthesis market for custom gene synthesis, 2018 - 2030 (USD Million)
    • 4.2.3 Gene Library Synthesis
      • 4.1.3.1 Global DNA synthesis market for gene library synthesis, 2018 - 2030 (USD Million)

Chapter 5 Application Analysis

  • 5.1 Research & Development
    • 5.1.1 Global DNA Synthesis Market For Research & Development, 2018 - 2030 (USD Million)
  • 5.2 Diagnostics
    • 5.2.1 Global DNA Synthesis Market For Diagnostics, 2018 - 2030 (USD Million)
  • 5.3 Therapeutics
    • 5.3.1 Global DNA Synthesis Market For Therapeutics, 2018 - 2030 (USD Million)

Chapter 6 Edn-Use Analysis

  • 6.1 Biopharmaceutical Companies
    • 6.1.1 Global DNA Synthesis Market For Biopharmaceutical Companies, 2018 - 2030 (Usd Million)
  • 6.2 Academic & Research Institutes
    • 6.2.1 Global DNA Synthesis Market For Academic& Research Institutes, 2018 - 2030 (Usd Million)
  • 6.3 Contract Research Organizations
    • 6.3.1 Global DNA Synthesis Market For Contract Research Organizations, 2018 - 2030 (Usd Million)

Chapter 7 Regional Business Analysis

  • 7.1 DNA synthesis Market: Regional Movement Analysis, 2022 & 2030
  • 7.2 North America
    • 7.2.1 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.2.2.2 Key country Dynamics
      • 7.2.2.3 Regulatory Framework
      • 7.2.2.4 Competitive Scenario
      • 7.2.2.5 Recent Developments
      • 7.2.2.6 Investments Scenario
    • 7.2.3 Canada
      • 7.2.3.1 Canada Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.2.3.2 Key country Dynamics
      • 7.2.3.3 Regulatory Framework
      • 7.2.3.4 Competitive Scenario
      • 7.2.3.5 Recent Developments
      • 7.2.3.6 Investments Scenario
  • 7.3 Europe
    • 7.3.1 Europe Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.2 Germany
      • 7.3.2.1 Germany Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.2.2 Key country Dynamics
      • 7.3.2.3 Regulatory Framework
      • 7.3.2.4 Competitive Scenario
      • 7.3.2.5 Recent Developments
      • 7.3.2.6 Investments Scenario
    • 7.3.3 U.K.
      • 7.3.3.1 U.K. Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.3.2 Key country Dynamics
      • 7.3.3.3 Regulatory Framework
      • 7.3.3.4 Competitive Scenario
      • 7.3.3.5 Recent Developments
      • 7.3.3.6 Investments Scenario
    • 7.3.4 France
      • 7.3.4.1 France Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.4.2 Key country Dynamics
      • 7.3.4.3 Regulatory Framework
      • 7.3.4.4 Competitive Scenario
      • 7.3.4.5 Recent Developments
      • 7.3.4.6 Investments Scenario
    • 7.3.5 Italy
      • 7.3.5.1 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.5.2 Key country Dynamics
      • 7.3.5.3 Regulatory Framework
      • 7.3.5.4 Competitive Scenario
      • 7.3.5.5 Recent Developments
      • 7.3.5.6 Investments Scenario
    • 7.3.6 Spain
      • 7.3.6.1 Spain Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.6.2 Key country Dynamics
      • 7.3.6.3 Regulatory Framework
      • 7.3.6.4 Competitive Scenario
      • 7.3.6.5 Recent Developments
      • 7.3.6.6 Investments Scenario
    • 7.3.7 Denmark
      • 7.3.7.1 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.7.2 Key country Dynamics
      • 7.3.7.3 Regulatory Framework
      • 7.3.7.4 Competitive Scenario
      • 7.3.7.5 Recent Developments
      • 7.3.7.6 Investments Scenario
    • 7.3.8 Sweden
      • 7.3.8.1 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.8.2 Key country Dynamics
      • 7.3.8.3 Regulatory Framework
      • 7.3.8.4 Competitive Scenario
      • 7.3.8.5 Recent Developments
      • 7.3.8.6 Investments Scenario
    • 7.3.9 Norway
      • 7.3.9.1 Norway Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.3.9.2 Key country Dynamics
      • 7.3.9.3 Regulatory Framework
      • 7.3.9.4 Competitive Scenario
      • 7.3.9.5 Recent Developments
      • 7.3.9.6 Investments Scenario
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.4.2.2 Key country Dynamics
      • 7.4.2.3 Regulatory Framework
      • 7.4.2.4 Competitive Scenario
      • 7.4.2.5 Recent Developments
      • 7.4.2.6 Investments Scenario
    • 7.4.3 China
      • 7.4.3.1 China Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.4.3.2 Key country Dynamics
      • 7.4.3.3 Regulatory Framework
      • 7.4.3.4 Competitive Scenario
      • 7.4.3.5 Recent Developments
      • 7.4.3.6 Investments Scenario
    • 7.4.4 India
      • 7.4.4.1 India Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.4.4.2 Key country Dynamics
      • 7.4.4.3 Regulatory Framework
      • 7.4.4.4 Competitive Scenario
      • 7.4.4.5 Recent Developments
      • 7.4.4.6 Investments Scenario
    • 7.4.5 Australia
      • 7.4.5.1 Australia Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.4.5.2 Key country Dynamics
      • 7.4.5.3 Regulatory Framework
      • 7.4.5.4 Competitive Scenario
      • 7.4.5.5 Recent Developments
      • 7.4.5.6 Investments Scenario
    • 7.4.6 Thailand
      • 7.4.6.1 Thailand Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.4.6.2 Key country Dynamics
      • 7.4.6.3 Regulatory Framework
      • 7.4.6.4 Competitive Scenario
      • 7.4.6.5 Recent Developments
      • 7.4.6.6 Investments Scenario
    • 7.4.7 South Korea
      • 7.4.7.1 South Korea Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.4.7.2 Key country Dynamics
      • 7.4.7.3 Regulatory Framework
      • 7.4.7.4 Competitive Scenario
      • 7.4.7.5 Recent Developments
      • 7.4.7.6 Investments Scenario
  • 7.5 Latin America (LATAM)
    • 7.5.1 Latin America Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.5.1.2 Key country Dynamics
      • 7.5.1.3 Regulatory Framework
      • 7.5.1.4 Competitive Scenario
      • 7.5.1.5 Recent Developments
      • 7.5.1.6 Investments Scenario
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.5.2.2 Key country Dynamics
      • 7.5.2.3 Regulatory Framework
      • 7.5.2.4 Competitive Scenario
      • 7.5.2.5 Recent Developments
      • 7.5.2.6 Investments Scenario
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.5.3.2 Key country Dynamics
      • 7.5.3.3 Regulatory Framework
      • 7.5.3.4 Competitive Scenario
      • 7.5.3.5 Recent Developments
      • 7.5.3.6 Investments Scenario
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.5.4.2 Key country Dynamics
      • 7.5.4.3 Regulatory Framework
      • 7.5.4.4 Competitive Scenario
      • 7.5.4.5 Recent Developments
      • 7.5.4.6 Investments Scenario
  • 7.6 Middle East and Africa (MEA)
    • 7.6.1 Middle East and Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.6.2.2 Key country Dynamics
      • 7.6.2.3 Regulatory Framework
      • 7.6.2.4 Competitive Scenario
      • 7.6.2.5 Recent Developments
      • 7.6.2.6 Investments Scenario
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.6.3.2 Key country Dynamics
      • 7.6.3.3 Regulatory Framework
      • 7.6.3.4 Competitive Scenario
      • 7.6.3.5 Recent Developments
      • 7.6.3.6 Investments Scenario
    • 7.6.4 UAE
      • 7.6.4.1 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.6.4.2 Key country Dynamics
      • 7.6.4.3 Regulatory Framework
      • 7.6.4.4 Competitive Scenario
      • 7.6.4.5 Recent Developments
      • 7.6.4.6 Investments Scenario
    • 7.6.5 Kuwait
      • 7.6.5.1 Kuwait Market Estimates and Forecast, 2018 - 2030 (USD Million)
      • 7.6.5.2 Key country Dynamics
      • 7.6.5.3 Regulatory Framework
      • 7.6.5.4 Competitive Scenario
      • 7.6.5.5 Recent Developments
      • 7.6.5.6 Investments Scenario

Chapter 8 Company Profiles

  • 8.1 Company Profiles
    • 8.1.1 Thermo Fisher Scientific, Inc.
      • 8.1.1.1 Company Overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Product Benchmarking
      • 8.1.1.4 Strategic Initiatives
    • 8.1.2 Twist Bioscience
      • 8.1.2.1 Company Overview
      • 8.1.2.2 Financial Performance
      • 8.1.2.3 Product Benchmarking
      • 8.1.2.4 Strategic Initiatives
    • 8.1.3 Bioneer Corporation
      • 8.1.3.1 Company Overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Product Benchmarking
      • 8.1.3.4 Strategic Initiatives
    • 8.1.4 Eton Bioscience
      • 8.1.4.1 Company Overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Product Benchmarking
      • 8.1.4.4 Strategic Initiatives
    • 8.1.5 LGC Biosearch Technologie
      • 8.1.5.1 Company Overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Product Benchmarking
      • 8.1.5.4 Strategic Initiatives
    • 8.1.6 IBA GmbH
      • 8.1.6.1 Company Overview
      • 8.1.6.1 Financial Performance
      • 8.1.6.2 Product Benchmarking
      • 8.1.6.3 Strategic Initiatives
    • 8.1.7 Eurofins Scientific
      • 8.1.7.1 Company Overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Product Benchmarking
      • 8.1.7.4 Strategic Initiatives
    • 8.1.8 Integrated DNA Technologies, Inc.
      • 8.1.8.1 Company Overview
      • 8.1.8.2 Financial Performance
      • 8.1.8.3 Product Benchmarking
      • 8.1.8.4 Strategic Initiatives
    • 8.1.9 Quintara Biosciences
      • 8.1.9.1 Company Overview
      • 8.1.9.2 Financial Performance
      • 8.1.9.3 Product Benchmarking
      • 8.1.9.4 Strategic Initiatives
    • 8.1.10 GenScript Biotech Corporation
      • 8.1.10.1 Company Overview
      • 8.1.10.2 Financial Performance
      • 8.1.10.3 Product Benchmarking
      • 8.1.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Incidence of Diseases
  • Table 4 Global DNA synthesis Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 6 Global DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 8 North America DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 10 North America DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 15 Canada DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 16 Canada DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 18 Europe DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Europe DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 20 Europe DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 Europe DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 22 Germany DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 23 Germany DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Germany DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 25 U.K. DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 26 U.K. DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 U.K. DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 28 France DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 29 France DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 France DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 31 Italy DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 32 Italy DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Italy DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 34 Spain DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 35 Spain DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Spain DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 38 Denmark DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 40 Sweden DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 41 Sweden DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Sweden DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 43 Norway DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 44 Norway DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Norway DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 50 Japan DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 51 Japan DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Japan DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 53 China DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 54 China DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 China DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 56 India DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 57 India DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 India DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 59 Australia DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 60 Australia DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 Australia DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 62 Thailand DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 63 Thailand DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Thailand DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 65 South Korea DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 66 South Korea DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 South Korea DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 68 Latin America DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 70 Latin America DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 Latin America DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 72 Brazil DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 73 Brazil DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Brazil DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 75 Mexico DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 76 Mexico DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Mexico DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 78 Argentina DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 79 Argentina DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Argentina DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 88 South Africa DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 89 South Africa DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 South Africa DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 91 UAE DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 92 UAE DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 UAE DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 DNA Synthesis Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2022
  • Fig. 14 DNA Synthesis Market: Product Key Takeaways
  • Fig. 15 Global DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 16 Global DNA Synthesis Market, for Service Type, 2018 - 2030 (USD Million)
  • Fig. 17 Global DNA Synthesis Market, for Oligonucleotide Synthesis, 2018 - 2030 (USD Million)
  • Fig. 18 Global DNA Synthesis Market, for Standard Oligonucleotide Synthesis, 2018 - 2030 (USD Million)
  • Fig. 19 Global DNA Synthesis Market, for Custom Oligonucleotide Synthesis, 2018 - 2030 (USD Million)
  • Fig. 20 Global DNA Synthesis Market, for Gene Synthesis, 2018 - 2030 (USD Million)
  • Fig. 21 Global DNA Synthesis Market, for Custom Gene Synthesis, 2018 - 2030 (USD Million)
  • Fig. 22 Global DNA Synthesis Market, for Gene Library Synthesis, 2018 - 2030 (USD Million)
  • Fig. 23 Global DNA Synthesis Market, for Application, 2018 - 2030 (USD Million)
  • Fig. 24 Global DNA Synthesis Market, for Research & Development, 2018 - 2030 (USD Million)
  • Fig. 25 Global DNA Synthesis Market, for Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 26 Global DNA Synthesis Market, for Therapeutics, 2018 - 2030 (USD Million)
  • Fig. 27 Global DNA Synthesis Market, for End-Use, 2018 - 2030 (USD Million)
  • Fig. 28 Global DNA Synthesis Market, for Biopharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 29 Global DNA Synthesis Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 30 Global DNA Synthesis Market, for Contract Research Organizations, 2018 - 2030 (USD Million)
  • Fig. 31 Global DNA Synthesis Market - Regional Outlook, 2022 & 2030
  • Fig. 32 North America DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.K. DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 38 France DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 39 Italy DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 43 Norway DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 45 Japan DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 46 China DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 47 India DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 48 Australia DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 53 Mexico DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 58 UAE DNA Synthesis Market, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait DNA Synthesis Market, 2018 - 2030 (USD Million)